FMO5 and Hypertension: Previous studies show that NADPH oxidase inhibitor apocynin or deficiency of gp91phox or p47phox attenuates the hypertensive response in the DOCA/salt-treated mice19,20, demonstrating that NADPH oxidase activity contributes to DOCA/salt-induced hypertension.